Company Filings — 23 January 2026

7 regulatory filings were published by NSE- and BSE-listed companies on 23 January 2026.

  1. Upcoming Q3FY26 Earnings Call Scheduled for January 30, 2026

    Strides Pharma Science Ltd · STAR · BSE ·

    • Strides Pharma has scheduled an earnings call to discuss Q3FY26 and nine months ended December 31, 2025 financial results • The call will feature Badree Komandur (Managing Director & Group CEO) and Vikesh Kumar (Group CFO) • Investors can join via pre-registration link or throu…

  2. Upcoming Q3FY26 Earnings Call Announcement

    Strides Pharma Science Ltd · STAR · BSE ·

    • Strides Pharma has scheduled an earnings call on January 30, 2026, at 4:30 PM IST to discuss Q3FY26 financial results • Senior management participants include Badree Komandur (Managing Director & Group CEO) and Vikesh Kumar (Group CFO) • Investors can pre-register online or joi…

  3. Board Meeting Scheduled for Q3 FY2025-26 Financial Results

    Bluspring Enterprises Limited · BLUSPRING · NSE ·

    • Board meeting scheduled for February 3, 2026 to consider and approve Q3 FY2025-26 unaudited financial results • Trading window closure in effect from January 1, 2026 to February 5, 2026 • Both standalone and consolidated quarterly results will be reviewed

  4. Kirloskar Pneumatic Reports 18.7% YoY Growth in Q3 FY26 Profit with Strong Compression Systems Performance

    Kirloskar Pneumatic Company Ltd · KIRLPNU · BSE ·

    • Revenue increased 18.7% YoY to ₹4,035 million in Q3 FY26 (vs ₹3,400 million in Q3 FY25) • Q3 FY26 profit before tax grew 26% YoY to ₹605 million (vs ₹480 million in Q3 FY25) • Compression Systems segment revenue rose 20.1% YoY to ₹3,792 million • Segment profit from Compression…

  5. Kirloskar Pneumatic Reports 26% YoY Growth in Q3 FY26 Profit with Strong Compression Systems Performance

    Kirloskar Pneumatic Company Ltd · KIRLPNU · BSE ·

    • Revenue increased 18.7% YoY to ₹4,035M in Q3 FY26 (vs ₹3,400M in Q3 FY25) and 6.7% QoQ • Q3 FY26 profit before tax grew to ₹605M, up 26% YoY despite ₹183M exceptional expense from new labor codes • Compression Systems segment revenue rose 20.1% YoY to ₹3,792M, with segment prof…

  6. Board Meeting Scheduled for Q3 FY2025-26 Financial Results Review

    The Motor & General Finance Limited · MOTOGENFIN · NSE ·

    • Board meeting scheduled for February 12, 2026 to consider Q3 FY2025-26 unaudited financial results (both standalone and consolidated) • Trading window closure in effect from January 1, 2026 through February 14, 2026 for designated persons • Results for the quarter ending Decemb…

  7. Board Meeting Scheduled for Q3 FY2026 Financial Results

    Ladderup Finance Ltd · 530577 · BSE ·

    • Board meeting to be held on Friday, January 30, 2026, to consider and approve unaudited financial results (Standalone and Consolidated) for Q3 and nine months ended December 31, 2025 • Trading window for company securities currently closed; will reopen 48 hours after declaratio…